essadii's profile picture. MD, FACC, Coronary and structural interventional cardiologist

Abdul Saadi

@essadii

MD, FACC, Coronary and structural interventional cardiologist

Abdul Saadi reposted

We spoke with @SCAI President Srihari S. Naidu, MD @SrihariNaiduMD), about his ambitious passion project in challenging the interventional cardiology field to achieve a 24-hour door-to-lactate clearance in cardiogenic shock care. citoday.com/articles/2025-…


Abdul Saadi reposted

There are plans to make RCT with PSA for HCM. Now there is a clear industry interest.

This post is unavailable.

Abdul Saadi reposted

First-in-human percutaneous transseptal Retrieveal of Embolized TRanscatheter valve In the lEft VEntricle (RETRIEVE) Now in press in JACC CVI Thank you to the patient/family and the Morristown team for the trust and support in me for this great save. @PhilGenereuxMD

g_giustinoMD's tweet image. First-in-human percutaneous transseptal Retrieveal of Embolized TRanscatheter valve In the lEft VEntricle (RETRIEVE)

Now in press in JACC CVI

Thank you to the patient/family and the Morristown team for the trust and support in me for this great save.

@PhilGenereuxMD
g_giustinoMD's tweet image. First-in-human percutaneous transseptal Retrieveal of Embolized TRanscatheter valve In the lEft VEntricle (RETRIEVE)

Now in press in JACC CVI

Thank you to the patient/family and the Morristown team for the trust and support in me for this great save.

@PhilGenereuxMD
g_giustinoMD's tweet image. First-in-human percutaneous transseptal Retrieveal of Embolized TRanscatheter valve In the lEft VEntricle (RETRIEVE)

Now in press in JACC CVI

Thank you to the patient/family and the Morristown team for the trust and support in me for this great save.

@PhilGenereuxMD
g_giustinoMD's tweet image. First-in-human percutaneous transseptal Retrieveal of Embolized TRanscatheter valve In the lEft VEntricle (RETRIEVE)

Now in press in JACC CVI

Thank you to the patient/family and the Morristown team for the trust and support in me for this great save.

@PhilGenereuxMD

Abdul Saadi reposted

This 🔑 image got left out!

realarainmd's tweet image. This 🔑 image got left out!

Abdul Saadi reposted

One of the great cases we’ve done in our 2 days CTO Club 2025 meeting. Crazy ostial LAD CTO w/ severe parietal calcium and aneurysmal morphology. Antegrade approach using Power Puncture of px cap w/ H14 followed by AW w/ H14 after failing AW Gladius > GN3. Also tried HDR. 4.0…


Tribute to the late George Mark great teacher and friend sorely missed @CooperIMRes

1/ OPTION Trial: A thread on a major study on stroke prevention post-AF ablation. Can left atrial appendage closure (LAAC) replace oral anticoagulation (OAC)? Let’s dive in. #CardioTwitter #AFib #EPeeps



Proves the concept. Maybe there is a market for a 35 mm (or larger) BEV that you can add a whopping 5+ !!! for AR and MS. Maybe the failures of 29 S3 are because “size matters ” ?These cases look great results congrats @pemarlor08


Abdul Saadi reposted

Another example of the utility of right parasternal view - a must in AS assessment. 70yo man with very poor acoustic window - highest gradient from subxiphoid view… then right parasternal. #echofirst #CardioTwitter @dr_benoy_n_shah @iamritu @argulian @bwoody58 @DrRajeshG1

lukasz_zydzik's tweet image. Another example of the utility of right parasternal view - a must in AS assessment.
70yo man with very poor acoustic window - highest gradient from subxiphoid view… then right parasternal.

#echofirst #CardioTwitter 
@dr_benoy_n_shah @iamritu @argulian @bwoody58 @DrRajeshG1
lukasz_zydzik's tweet image. Another example of the utility of right parasternal view - a must in AS assessment.
70yo man with very poor acoustic window - highest gradient from subxiphoid view… then right parasternal.

#echofirst #CardioTwitter 
@dr_benoy_n_shah @iamritu @argulian @bwoody58 @DrRajeshG1

Abdul Saadi reposted

First commercial case of transcatheter mechanical leaflet laceration with ShortCut in the World performed at @AtlanticHealth ! Bilateral leaflet splitting in <15 minutes to facilitate ViV Happy to be able to offer multiple options for leaflet modification to our patients…

g_giustinoMD's tweet image. First commercial case of transcatheter mechanical leaflet laceration with ShortCut in the World performed at @AtlanticHealth !

Bilateral leaflet splitting in &amp;lt;15 minutes to facilitate ViV

Happy to be able to offer multiple options for leaflet modification to our patients…
g_giustinoMD's tweet image. First commercial case of transcatheter mechanical leaflet laceration with ShortCut in the World performed at @AtlanticHealth !

Bilateral leaflet splitting in &amp;lt;15 minutes to facilitate ViV

Happy to be able to offer multiple options for leaflet modification to our patients…

The main dilemma for all mitral interventions is that we keep putting circular-shaped devices balloons and stented valves in this oval structure


Abdul Saadi reposted

Let's put to bed the rewrite of history that the Covid vaccines never worked Here's the original Pfizer trial from 2020 Red line - cases in vaccinated Blue line - cases in unvaccinated Not hard to see Then the virus mutated and it became less effective Things change!!

DrNeilStone's tweet image. Let&apos;s put to bed the rewrite of history that the Covid vaccines never worked

Here&apos;s the original Pfizer trial from 2020

Red line - cases in vaccinated
Blue line - cases in unvaccinated

Not hard to see

Then the virus mutated and it became less effective

Things change!!

Abdul Saadi reposted

UNICORN or BASILICA for VIV? @PCRonline how to choose between the two? @g_giustinoMD

Another week, another successful TAVR ViV UNICORN at @AtlanticHealth. Time from first burn/traversal to valve implantation: 13 minutes. Complete left leaflet laceration accomplished with TrueDil 16 mm balloon after pre-dilating with 4.0 NC balloon. Excellent final LM flow…



Going down memory lane @SCAI at some point there was an “&” in the name.


Thigh’s Vineberg

Bypass is 4 YO. No outflow. Yet remains patent. #GSV



Abdul Saadi reposted

We're proud to celebrate 70,000+ patients with the FlowSaver Blood Return System! Stop by Booth #109 at #PERT2024 to learn how #FlowTriever and #FlowSaver are intentionally designed for safe blood return. #FlowTriever #PulmonaryEmbolism #Boston #BloodReturn

InariMedical's tweet image. We&apos;re proud to celebrate 70,000+ patients with the FlowSaver Blood Return System!
 
Stop by Booth #109 at #PERT2024 to learn how #FlowTriever and #FlowSaver are intentionally designed for safe blood return.
 
#FlowTriever #PulmonaryEmbolism #Boston #BloodReturn

Abdul Saadi reposted

Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation: @NEJM 🥸 MATTERHORN Trial: meaning of Matterhorn: a mountain of the Alps, straddling the main watershed and border between Italy and Switzerland... 😱 Creative names: Summary 👇👇👇

DrDamluji's tweet image. Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation: @NEJM 

🥸 MATTERHORN Trial: meaning of Matterhorn: a mountain of the Alps, straddling the main watershed and border between Italy and Switzerland...

😱 Creative names: Summary

👇👇👇

Abdul Saadi reposted

New ESC Chronic Coronary Syndrome Guidelines just out. For LM stenoses w/ low Syntax Score, both surgery and PCI - as long as full revasc is possible - have Class IA recommendation. Image-guided PCI has Class IA for LM / bifu / long lesions #Cardiotwitter @escardio #ESCCongress

Steph_Achenbach's tweet image. New ESC Chronic Coronary Syndrome Guidelines just out. For LM stenoses w/ low Syntax Score, both surgery and PCI - as long as full revasc is possible - have Class IA recommendation. Image-guided PCI has Class IA for LM / bifu / long lesions
#Cardiotwitter @escardio #ESCCongress

Abdul Saadi reposted

GLP-1 RA reduces CV events & CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes Our most comprehensive analysis yet, #simpub in @CircAHA for #ESCCongress ahajournals.org/doi/abs/10.116…

brendonneuen's tweet image. GLP-1 RA reduces CV events &amp;amp; CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes

Our most comprehensive analysis yet, #simpub in @CircAHA for #ESCCongress

ahajournals.org/doi/abs/10.116…
brendonneuen's tweet image. GLP-1 RA reduces CV events &amp;amp; CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes

Our most comprehensive analysis yet, #simpub in @CircAHA for #ESCCongress

ahajournals.org/doi/abs/10.116…
brendonneuen's tweet image. GLP-1 RA reduces CV events &amp;amp; CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes

Our most comprehensive analysis yet, #simpub in @CircAHA for #ESCCongress

ahajournals.org/doi/abs/10.116…
brendonneuen's tweet image. GLP-1 RA reduces CV events &amp;amp; CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes

Our most comprehensive analysis yet, #simpub in @CircAHA for #ESCCongress

ahajournals.org/doi/abs/10.116…

Loading...

Something went wrong.


Something went wrong.